Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Cancer Lett. 2011 May 1;304(1):1-7. doi: 10.1016/j.canlet.2010.12.023. Epub 2011 Mar 2.

Anterior gradient 2: a novel player in tumor cell biology.

Author information

1
Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic.

Abstract

AGR2 has evolutionarily conserved roles in development and tissue regeneration and is linked with several human cancers. The exact functions and regulation of AGR2 are poorly understood, but current data identify AGR2 as a clinically relevant factor that modulates the behavior and response of hormone-dependent cancers (breast, prostate) and hormone-independent cancers (colorectal, pancreatic, esophageal and other common cancers). AGR2 protein expression induces metastasis, acts as a p53 tumor suppressor inhibitor and survival factor, participates directly in neoplastic transformation and is involved in drug resistance. Thus, AGR2 is an important tumor biomarker and negative prognostic factor potentially exploitable in clinical practice.

PMID:
21371820
DOI:
10.1016/j.canlet.2010.12.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center